Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyanine Green (ICG) dye allows for better identification of tumor tissue during surgical procedures. Participation will include standard of care visits along with administration of ICG dye and imaging during surgery. Participation in this study will last approximately 6 weeks.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby w wieku 18 lat lub starsze.
- •Osoby z rakiem płaskonabłonkowym pochodzenia błony śluzowej, które mogą mieć nawrót choroby.
- •Osoby, które są dobrymi kandydatami do operacji, zgodnie z opinią lekarza.
- •Osoby zdolne do wyrażenia świadomej zgody na udział w badaniu.
✗ Disqualifies
- •Kobiety w ciąży, karmiące piersią lub planujące zajść w ciążę podczas badania.
- •Znana alergia na jod lub skorupiaki.
- •Poważne problemy z wątrobą lub nerkami.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 7, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Medical University of South Carolina Hollings Cancer Center
Charleston, United States
Trial contact
HCC Clinical Trials Office
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.